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Effectiveness of robot-assisted therapy on stroke patients 
with upper extremity impairment 
 
 
Prepared by:   Marisa Hurley, Occupational Therapy Student, Pacific University 
   E-mail: hurl2557@pacificu.edu 
 
Date:   November 16, 2009 
 
 
CLINICAL SCENARIO: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOCUSED CLINICAL QUESTION: 
 
What is the evidence that robot-assisted therapy is more effective for stroke patients in 
the post-acute phase with upper extremity impairment than conventional or no 
therapy? 
 
 
 
SUMMARY of Search, ‘Best’ Evidence’ appraised, and Key Findings:     
 
From four individual studies and one systematic review the evidence is mixed as to 
the efficacy of robot-assisted therapy in treatment of post-acute stroke patients. 
Three studies (Finley, Fasoli, Dipietro, Ohlhoff, MacClellan, Meister, …& Hogan, 
2005; MacClellan, Bradham, Whitall, Volpe, Wilson, Ohlhoff, … & Bever, 2005; and 
Fasoli, Krebs, Stein, Frontera, & Hogan, 2003) used a before-and-after design to 
examine the effects of robot-assisted therapy after no therapy.  All three studies 
concluded that robot-assisted therapy was effective in decreasing motor 
impairments in the affected upper extremity but the results were really only 
applicable to patients with severe impairment, not minimal or moderate impairment.  
For all three studies, the results of improved upper extremity function were 
Robot-assisted therapy refers to a recent trend of using robotic devices for 
rehabilitation of persons with mild to severe motor impairments as a result of 
neurologic injury.  This rehabilitation approach serves to help persons who cannot be 
helped with constraint-induced movement therapy which is shown to benefit persons 
with high-level motor impairments.  For patients without active movement in the wrist 
and hand, many conventional therapy methods have proven ineffective at regaining 
function in the paretic arm.  Robot-assisted therapy is delivered with one of several 
robots (i.e. MIT-MANUS, InMotion2, MIME) aimed at providing high intensity repetitive 
movements in a safe environment in order to improve functional and motor recovery 
in the paretic upper limb.  While the specific mechanisms underlying motor recovery 
and its relationship to cortical reorganization are not well understood, it has been 
determined through several studies and one particular systematic review (Kwakkel, 
Kollen, & Krebs, 2008) that there is a positive trend in favour of robotic therapy for 
improving motor recovery in persons with upper limb impairment. 
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maintained for three months post-treatment.  Fasoli et al (2003) compared the use 
of a sensorimotor robot-assisted program versus a progressive-resistive robot-
assisted program and found that the progressive-resistive therapy group showed 
more significant improvements in wrist and hand movement than that of the 
sensorimotor group, suggesting that the type of robot-assisted therapy does make a 
difference in treatment results. 
 
The randomized controlled trial (Lum et al, 2002) found robot-assisted therapy had 
advantages after 2 months of treatment compared to the control group which 
received equal intensity conventional therapy interventions.  The results found 
decreased impairment, improved strength, and increased reach extent in the 
treatment group to surpass the results of the control group though it was not 
determined whether the same effects of robot-assisted therapy could be duplicated 
by a human therapist to produce similar results.  Differences between the two 
treatment groups could be accounted for by the difference in content for each group 
meaning that the results may not be as suggestive as originally thought. 
 
The systematic review also provided mixed results as to the effectiveness of robot-
assisted therapy to positively affect both motor recovery and functional ability to 
complete activities of daily living.  Kwakkel, Kollen, & Krebs (2008) included ten 
well-performed randomized controlled trials of robot-assisted therapy and divided 
them according to which outcome measurement was used.  Seven studies used the 
Fugl-Meyer or the Chedoke-McMaster Stroke Assessment Scale to evaluate motor 
recovery.  Five studies used the Functional Independence Measure to evaluate 
activities of daily living.  Of the seven studies evaluating motor recovery, only five 
found statistically significant results suggesting robot-assisted therapy was more 
effective than conventional therapy methods though four studies reported 
statistically nonsignificant results of robot-assisted therapy over conventional 
therapy.  Overall, in regards to motor recovery when measured with the Fugl-Meyer 
or Chedoke-McMaster this systematic review suggests a positive trend toward 
robot-assisted therapy compared with conventional treatment modalities.  There 
were no reported statistically significant results in favour of the experimental group 
for the four randomized controlled trials evaluating activities of daily living using the 
Functional Independence Measure. 
 
 
 
CLINICAL BOTTOM LINE:     
The results of this limited evidence-based literature review suggest that 
occupational therapy research must continue in order to establish the effectiveness 
of robot-assisted therapy before concluding that it is a successful treatment for 
stroke patients with upper extremity impairment.  The experimental studies used 
different programs of this intervention and found mixed results as to the efficacy of 
this treatment approach.  The difference between study subjects may lead 
researchers to conclude that results from one client population may not generalize 
to another.  The overall intensity of robot-assisted therapy programs may allow the 
client to become more involved in their treatment and recover functional movement 
more quickly than with human conventional therapy treatments.  The maintenance 
of positive results is not known beyond six months and the mixed results suggest 
that further research is needed. 
 Prepared by Marisa Hurley (11/16/09) 
3 
Limitation of this CAT:  This critically appraised topic has not been peer-reviewed by 
other independent reviewers and is not an all-extensive review of all the literature 
available on this topic.  In addition, this reviewer does not claim to be an expert on the 
topic. 
 
 
SEARCH STRATEGY: 
 
Terms used to guide Search Strategy: 
 
• Patient/Client Group: Stroke patients with upper extremity impairment 
 
• Intervention (or Assessment): Robot-assisted therapy 
 
• Comparison: Conventional therapy   
 
• Outcome(s): Improve upper extremity function more with robot-assisted therapy
   
 
Databases and 
sites searched 
Search Terms Limits used 
OT Search 
 
OVID Medline 
 
Rehabilitation 
Reference Center 
 
CINAHL 
Cerebrovascular accident, stroke, 
upper extremity, hemiparesis, 
robot-assisted therapy, hemiplegia, 
robot 
English language 
Peer-reviewed 
articles 
Published since 
2000 
 
 
INCLUSION and EXCLUSION CRITERIA  
 
• Inclusion:  Studies were only included if they were in the English language, peer-
reviewed, Level I studies, and published after the year 2000; studies where the 
patient had either moderate or severe impairment from stroke and where robot-
assisted therapy was the primary intervention approach being investigated; and 
participants were adults. 
 
• Exclusion:  Studies were excluded if an occupational therapist was not included in 
the authors to assure relevance to the field of occupational therapy; if there was 
only mild impairment of the upper extremity; if upper extremity impairment did not 
result from a stroke; and studies with no quantitative measurement of function.  
While all levels of evidence were searched for, only Level I evidence was used.  
Also excluded were journal articles where development of robot-assisted 
technology was described but no intervention occurred. 
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RESULTS OF SEARCH 
 
Five relevant studies were located and categorised as shown in Table 1 (based on 
Levels of Evidence, Centre for Evidence Based Medicine, 1998) 
Table 1:  Summary of Study Designs of Articles retrieved 
Study Design/Methodology of 
Articles Retrieved 
Level Number 
Located 
Author (Year) 
 
Systematic Review 
 
 
1a 
 
1 
Kwakkel, G., Kollen, B.J., 
Krebs, H.I. (2008) 
 
Before-and-After 
 
1b 
 
3 
• Finley, M.A., Fasoli, S.E., 
Dipietro, L., Ohlhoff, J., 
MacClellan, L., Meister, 
C., …Hogan, N. (2005) 
• MacClellan, L.R., 
Bradham, D.D., Whitall, 
J., Volpe, B., Wilson, 
P.D., Ohlhoff, J., 
…Bever, C.T. Jr. (2005) 
• Fasoli, S.E., Krebs, H.I., 
Stein, J., Frontera, W.R., 
Hogan, N. (2003) 
 
Randomized Controlled Trial 
 
 
1b 
 
1 
Lum, P.S., Burgar, C.G., 
Shor, P.C., Majmundar, M., 
Van der Loos, M. (2002) 
 
For Table x: Characteristics of included studies, see pages 11 and 12. 
 
BEST EVIDENCE 
The following study/paper was identified as the ‘best’ evidence and selected for critical 
appraisal.  Reasons for selecting this study were: 
• It shows the mixed results of robotic therapy common in the current research 
• It suggests a positive trend toward robotic therapy 
• It is the highest level of evidence and examines only well-conceived randomized 
controlled trials 
 
 
SUMMARY OF BEST EVIDENCE 
Table 2:  Description and appraisal of Effects of robot-assisted therapy on upper limb 
recovery after stroke: A systematic review by Kwakkel, G., Kollen, B.J., & Krebs, H.I., 
2008 
 
 
Aim/Objective of the Study/Systematic Review: The aim of this systematic review 
was to examine the evidence for the efficacy of using robot-assisted therapy over 
conventional treatment to improve motor and functional recovery in patients with 
stroke. 
 
Study Design: This systematic review initially located 173 articles matching criteria for 
the literature search.  It was then narrowed down to 87 studies which were considered 
 Prepared by Marisa Hurley (11/16/09) 
5 
relevant for further screening of abstracts.  That screening resulted in only 44 studies 
being selected and 34 of those studies were excluded due to an inappropriate 
research design (ten were critical or narrative reviews and 24 were noncontrolled 
trials, 1 was a pre-experimental study and 2 were controlled studies that did not 
measure motor and/or functional recovery of the upper paretic limb), resulting in only 
ten studies being identified as relevant.  This review, therefore, examined ten studies, 
all randomized controlled trials, with respect to functional recovery (as measured with 
the Functional Independence Measure) and motor recovery (as measured with the 
Fugl-Meyer and Chedoke-McMaster Stroke Assessment Scale).  As this approach is 
still recent in its development and implementation, it was appropriate to include only 
ten studies for review. 
 
Search Strategy: The authors performed a literature search on the computer using 
multiple databases including Medline, CINAHL, EMBASE, Cochrane Controlled Trials 
Register, DARE, SciSearch, DocOnline, and PEDro.  Studies were collected through 
October 2006.  Keywords used in the search included cerebral vascular accident, 
cerebral vascular disorders, stroke, paresis, hemiplegia, upper extremity, arm, and 
robot (and all word combinations that began with the term “robot”).  These keywords 
are quite thorough and encompass nearly all, if not all, articles pertaining to this 
subject matter.  The theoretical base for this treatment was not considered in the 
keywords as it is not fully developed at this point and the theoretical bases of each 
study may vary slightly.  Only articles written in English, Dutch, and German 
languages were included in the search parameters. 
 
Selection Criteria:  Inclusion criteria were that (1) patients were diagnosed with 
cerebral vascular accident; (2) effects of robot-assisted therapy for the upper limb 
were investigated; (3) the outcome was measured in terms of motor and/or functional 
recovery of the upper paretic limb; and (4) the study was a randomized clinical trial 
(RCT).  Some of the exclusion criteria for selecting studies included studies that 
compared the effects of 2 different types of robot-assisted therapy and studies of 
persons with chronic impairment due to stroke that compared discharge outcomes 
with preintervention stable scores.  Before selecting final studies for the review, each 
proposed study was rated using the PEDro scale and scored by two of the authors of 
the review.  When no consensus was reached between reviewers, a third reviewer 
made the final decision.  PEDro scores of 4 points or more were classified as “high 
quality,” whereas studies with 3 points or less were classified “low quality.”  Ten 
studies were considered relevant and appropriate for analysis with the range of the 
start of therapy going from 1 week after stroke to more than 6 months after stroke.  
Specific details of each RCT can be found in Table 1 of the systematic review and a 
similar table of results is attached to this CAT. 
 
Methods of Analysis:  Studies were analysed according to whether they measured 
the outcome of functional or motor recovery.  Of ten available studies, seven 
examined motor recovery.  All seven of these studies used the Fugl-Meyer 
Assessment scale to measure motor recovery and one study used the Chedoke-
McMaster Stroke Impact Scale.  In these studies there were a total of 218 patients 
with stroke involved.  Results of these studies are varied as only five studies reported 
statistically significant effects for motor recovery in favour of the experimental group 
and four studies did not report any significant difference between the experimental and 
control groups.  An overall statistically nonsignificant (0.65, 95% confidence interval 
[CI] -0.02 to 1.33; Z=1.90, P=.06) heterogenous summary effect size [SES] (χ2 =40.82, 
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P<.001) was found in favour of the robot-assisted therapy. Heterogeneity was due 
mainly to Hesse and colleagues’ study so when not included it showed a homogenous 
SES (χ2 =4.35, P=.60) in favour of shoulder-elbow arm robotics (Z=2.32, P<.026).  A 
meta-analysis of robot-assisted therapy trails on motor recovery can be found in 
Figure 1 of the document, as replicated below. 
 
                              
 
Out of the ten available studies, five examined functional recovery using the 
Functional Independence Measure.  There were 139 patients with stroke involved in 
this analysis.  None of the studies reported significant effects for ADL (functional 
recovery) in favour of the experimental group.  A homogenous nonsignificant SES was 
found (χ2 = 0.50, P>.05) for robot-assisted therapy.  A meta-analysis of robot-assisted 
therapy trails on activities of daily living can be found in Figure 2 of the document, as 
replicated below. 
 
               
 
 
Original Authors’ Conclusions:  Analysis of these studies shows a positive trend 
toward robot-assisted therapy in regards to the 218 patients with stroke when 
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measured with the Fugl-Meyer assessment scale or the Chedoke-McMaster Stroke 
Impact Scale.  Methods of analysis were appropriate when calculating a summary 
effect size for a group of quantitative studies.  Recovery occurred primarily in the 
proximal upper limb more significantly than when compared to conventional treatment 
modalities.  Due to the calculation of summary effect sizes (SES) according to a 
random effects model, heterogeneity was determined in one calculation due to a 
larger confidence interval.  The Hesse and colleagues study did not measure proximal 
shoulder and elbow movements as the other studies had which affected that one 
calculation of results.   
 
Overall, the “significant, moderate SES of upper arm robotics on motor control based 
on FMA and CMSA scales denotes a mean overall change of 7% to 8% in motor 
control of the upper limb in favour of the robot-assisted therapy.” (p. 117) 
As for the effect of robot-assisted therapy on functional recovery, as measured by FIM 
scores on ADLs, there were no noted significant improvements in any study.  The 
authors suggest that this may be due to the inappropriate nature of the FIM at 
measuring the dexterity of the upper paretic limb.  It is suggested that other 
assessments such as the Wolf Motor Function Test or the Jebsen Test may be more 
effective at drawing out changes in upper paretic limb dexterity due to robot treatment. 
 
The authors of this review concluded that high intensity robot-assisted therapy creates 
more movements in patients than elicited by other forms of therapy such as electric 
stimulation, free reaching, and neurodevelopmental therapy.  These high intensity 
repetitive movements are likely what make robot-assisted therapy effective.  More 
research is still needed to determine if efficacy with this treatment comes from these 
high intensity training or to the treatment modality itself.  It is also important to 
consider the cost-effectiveness of this treatment approach though more research is 
necessary in order to obtain this information.  Through all of this data collection the 
authors have concluded that robotic assisted devices have the potential for eliciting 
improvements in proximal upper limb function with stroke patients.  More research is 
needed to determine any potential for improving functional recovery as evidenced 
through activities of daily living. 
 
Limitations of this study are noted by the authors in their final discussion.  One 
limitation is the possibility of the same clients participating in multiple studies included 
in this review which would stifle data collected and decrease generalizability of results.  
Also, the authors complied the Fugl-Meyer and Chedoke-McMaster scores since both 
are based off Brunnstrom stages of recovery; however, both assessments measure 
different dimensions of motor function and so compiling them together may create a 
dimensionless SES.  Another limitation is in the compiling of different methods of 
robot-assisted interventions to obtain one overall effect size.  The problem with this is 
that different robots deliver therapy differently and focus on different areas of upper 
limb function and so results may be difficult to interpret as to which system is most 
effective.  This is a similar problem for the control group as each control group 
received a different type of treatment and pooling them together as one treatment may 
give inaccurate results as to the efficacy of conventional treatment methods.  These 
limitations all imply the need for more quality randomized controlled trials to be 
performed.  There may have been more quality studies in other languages not 
included in this review which may be one last important limitation. 
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Critical Appraisal:  
 
Validity: This systematic review is a rather well-inclusive search of available research 
articles on this subject matter as they searched through a wide range of articles on the 
available topic and narrowed it down to studies that were so similar.  Their selection of 
articles in only English, German, and Dutch may have had a slight limiting effect on 
available studies though not enough to significantly affect the results.  Their utilization 
of PEDro scores for determining methodological quality may also be inappropriately 
influencing selection of some studies.  It is important to consider the PEDro score of 
an article in order to acknowledge if the randomized controlled trials were well-done.  
However, there is no information given as to why authors of this review chose 4 or 
higher as a cut-off score for a “high quality” study.  There are a possible 10 points for 
RCTs using the PEDro scale and so a score of 4 may not be well-done at all, 
depending on which areas points are accumulated in.  It may have been more 
appropriate for Kwakkel, Kollen, and Krebs to include which PEDro sub-test items they 
were most interested in ensuring that their studies scored on to let the audience know 
that studies being chosen are, in fact, well-done methodologically.  A score higher 
than 4 for “high quality” would better differentiate “high quality” studies from 
“moderate” and “low” quality studies, represented by a PEDro score less than 3.  This 
may limit some studies from inclusion though it would weed out studies that are not as 
methodologically sound as the authors desired. 
 
Interpretation of Results: Results are well-documented in stream-lined tables, 
making it easier to evaluate the original RCT’s outcomes and results.  Outcomes of 
interest were similar in all RCTs evaluated in the review though motor recovery 
outcome measurements (Fugl-Meyer and Chedoke-McMaster) were compiled 
together though they measure different functional movements as the Chedoke-
McMaster evaluated wrist-hand motion and the Fugl-Meyer evaluated both proximal 
and distal motion.  This may inappropriately influence results if the treatment is less 
effective for wrist and hand motions than for proximal shoulder and elbow motions 
resulting in a smaller effect size.  In calculation of effect size for motor recovery a 
statistically nonsignificant effect size of 0.65 was found in favour of the robot-assisted 
therapy though it is not a strong enough indicator to conclude a positive trend though it 
is strong enough to suggest further research for clarification of efficacy.  Results 
regarding functional recovery evaluating ADLs with the Functional Independence 
Measure appropriately concluded that there were no significant improvements in the 
experimental group.  This may, however, be due in part to the limitations of the FIM at 
appropriately analysing distinct upper extremity motions necessary to complete certain 
components of ADL activities. 
 
Summary/Conclusion: This systematic review, while not all-inclusive of all available 
randomized controlled trials, was well-done and evaluated the included studies 
appropriately leading to the appropriate conclusion that more research is needed to 
determine efficacy of this treatment approach.  There are, as always, limitations with 
this review and future research should attempt to address and correct those 
limitations.  More randomized controlled trials need to be done in order to determine 
the mechanisms of motor recovery and cortical reorganization in order to more 
effectively determine which aspects of robot-assisted therapy are beneficial for 
improving impairment in stroke patients.  This review should incite researchers to do 
more studies to examine this link and to demonstrate that moderate-to-severe 
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impairments in stroke patients can be improved functionally with methods more 
effective than those used in conventional therapy.  A future systematic review should 
include studies with similar outcome measurements (to avoid compiling two different, 
possibly dissimilar, measurements), similar populations (i.e. same type of stroke, 
same impairment level at baseline), and a more functional outcome measurement tool 
than the Functional Independence Measure in order to better establish a connection 
between robot-assisted therapy and functional recovery in ADLs. 
 
 
 
 
IMPLICATIONS FOR PRACTICE, EDUCATION and FUTURE RESEARCH 
 
All of the five studies synthesized in this CAT concluded that there are potential 
benefits of robot-assisted therapy on upper extremity impairment in stroke patients.  
Those benefits may not be well-understood or well-documented in all studies which is 
why there is a need for more research.  The most common problem in these studies is 
the small sample size which may result in an insignificant effect size.  The systematic 
review critiqued herein provides further evidence for the need for more research, 
particularly in relation to determining the cost-effectiveness of this treatment approach.  
It is necessary to determine if the cost outweighs the benefits of this modality.  From 
all included studies benefits can be determined as: (1) potential for improving motor 
recovery in the paretic upper extremity, (2) increased compliance, and (3) delivering 
highly repetitive and functional movements which may not be as effective when 
replicated by a human therapist.  Future research needs to determine if there are 
certain stroke populations that this therapy approach works better with.  This may, 
perhaps, be an appropriate time to consider qualitative research approaches such as 
single-subject research design in order to determine if this approach is appropriate for 
one patient that is not benefitting from conventional therapy and risks being 
discharged from therapy due to lack of progress.  In this situation, however, it would 
be important to choose an appropriate outcome measurement to appropriately detect 
any changes in functional recovery, something the FIM was not able to do. It is also 
important to consider in future research if this modality is effective enough to risk 
spending so much money on.  The cost of this treatment approach, as well as the 
potential for harm, was not discussed in any study though the MIT-MANUS robot 
averages around $65,000 for the wrist robot and $70,000 for the planar (shoulder) 
robot.  That is a very high cost for purchasing equipment that does not have an 
established and well-agreed upon rate of success with patients.  It is important for 
practitioners to have the evidence for efficacy before considering whether or not to use 
this with their own patients.   
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Table x: Characteristics of included studies  
 
 
Study 1  
MacClellan et al (2005) 
Study 2  
Lum, Burgar, Shor, 
Majmundar, & Van der 
Loos (2002) 
Study 3  
Fasoli, Krebs, Stein, 
Frontera, & Hogan (2003) 
Study 4 
Finley et al (2005) 
Intervention 
investigated 
Robot-assisted therapy 
with InMotion2 
Robot-assisted therapy with 
MIME system 
Robot-assisted therapy with 
MIT-MANUS (progressive-
resistive and sensorimotor 
groups) 
Robot-assisted therapy 
with InMotion2 
Comparison 
intervention  
Baseline evaluation 
with no treatment.  
(Subjects with severe 
impairment were 
compared with subjects 
with moderate 
impairment) 
Conventional therapy Baseline evaluation with no 
treatment 
Baseline evaluation with 
no treatment 
Outcomes 
used 
Upper-limb motor 
function (shoulder and 
elbow) was measured 
with the Upper-limb 
Motor Status Score, 
Wolf Motor Function 
Test, Motor Power 
Assessment, and Fugl-
Meyer. 
Function, strength, and 
reach were measured by the 
Fugl-Meyer, Barthel Index, 
FIM, torque measurements 
of strength, and a computer 
digitizer measuring reach. 
Muscle spasticity, 
synergistic and isolated 
movement patterns of 
upper-limb; grasp; strength 
(shoulder and elbow); upper 
extremity motor function; 
and pain.  Measured by 
Modified Ashworth Scale, 
Fugl-Meyer test of motor 
power, Medical Research 
Council test of motor 
power, Motor Status Scale, 
and self-reports of pain by 
the client 
Motor performance of 
upper limb measured 
with Wolf Motor 
Function Test, Motor 
Power Assessment, 
Fugl-Meyer UL 
Assessment, Self-
Administered Stroke 
Impact Scale, aiming 
error, mean speed, peak 
speed, and movement 
duration 
Findings  Significant 
improvement in Fugl-
Meyer scores and 
Compared with the control 
group, the treatment group 
had higher rates of 
The Fugl-Meyer test 
indicated statistically 
significant and large effect 
Following robot-assisted 
therapy treatment the 
following results were 
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Motor Power 
Assessment scores 
were noted for the 
subjects with severe 
impairment.  Subjects 
with moderate 
impairment also had 
statistically significant 
results on the Motor 
Power Assessment.  In 
the moderate group 
there was a positive 
trend for the Fugl-
Meyer and Wolf 
Median Time though 
not statistically 
significant.  The Wolf 
Functional Ability 
measure indicated a 
small but significant 
improvement in the 
group with moderate 
but not severe 
impairment. 
decreased impairment, 
improved strength, and 
increased reach extent.  The 
two groups, however, were 
not matched in terms of 
content so some results may 
be misinterpreted. 
The treatment group had 
significantly greater 
improvements on the 
proximal and distal portions 
of the Fugl-Meyer 
compared with the control 
group but after 6 months of 
treatment there were no 
differences between groups.  
The robot group had 
significantly greater gains in 
FIM scores at 6-month 
follow-up.  The robot group 
also had significantly 
greater improvements in 
proximal arm strength and 
reach extent than the 
control. 
of therapy as well as the 
Motor Status Scale score for 
shoulder and elbow, and the 
MRC tests of motor power; 
Motor Status Scale score for 
wrist and hand found a 
statistically significant but 
moderate effect.  Discharge 
pain was not statistically 
significant when compared 
to shoulder pain at 
admission.  A 
nonsignificant and small 
effect of robotic therapy on 
muscle tone was found by 
the Modified Ashworth 
Scale.  Findings also 
suggest the progressive-
resistive group had a 
statistically significant and 
large effect compared with 
the sensorimotor group on 
the MSS wrist and hand 
score. 
obtained: statistically 
significant 
improvements in the 
Fugl-Meyer Assessment 
score and Motor Power 
Assessment; no 
significant changes 
found on the Wolf 
Motor Function Test or 
Stroke Impact Scale; 
significantly reduced 
aiming error and 
movement duration; 
increased mean speed 
and mean peak:speed 
ratio.  At 3-month 
follow-up upper 
extremity impairment 
was not statistically 
different compared with 
posttreatment levels. 
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Characteristics of studies included in the systematic review by Kwakkel, Kollen, & Krebs (2008) 
 
Reference Stroke Type Severity 
(F-M 
[UL] at 
baseline) 
Start of 
RT/CT 
(E/C) 
Type of 
Intervention 
(E/C) 
Intervention 
Categories 
Daily 
(min) 
RT 
(E/C) 
Daily 
(min) 
CT 
(E/C) 
Mean age 
(years) 
(E/C) 
Outcome Author 
conclusion 
Aisen 
1997 
Hemhorragic, 
ischemic 
13.8/17.1 2.8/3.3wk RT vs. robot 
exposure 
(control) 
MIT-
MANUS 
60/0 ±0/10 58.5/63.3 F-M 
FIM 
Significant 
difference in 
motor 
recovery 
(acute 
patients) 
Burgar 
2000 
All types 24.8/21.8 26.5/26.4 
mo 
RT vs. neuro-
developmental 
therapy 
MIME 36/0 0/36 64.4/63.3 F-M 
FIM 
Significant 
difference in 
motor 
recovery 
(chronic 
patients) 
Kahn 
2000 
? ? >6 mo RT vs. 
unassisted, 
unrestrained 
reaching 
exercises 
ARM 
Guide 
? ? ? Ch McM Repetitive 
movements 
seem to be 
the primary 
stimuli to 
recovery 
Volpe 
2000 
Hemorrhagic, 
ischemic 
8.6/10.5 22.5/26.0 
days 
RT vs. robot 
exposure 
(control) 
MIT-
MANUS 
60/0 0/12 62/67 F-M Improvement 
of the motor 
performance 
of the 
exercised 
shoulder and 
elbow 
Fasoli 
2004 
Hemorrhagic, 
ischemic 
8.6/10.5 9/10 days RT vs. robot 
exposure 
(control) 
MIT-
MANUS 
60/0 0/12 62/67 F-M Intensive 
therapy leads 
to better 
recovery 
after stroke 
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Lum 2002 All types 24.8/26.6 30.2/28.8 
mo 
RT vs. neuro-
developmental 
therapy 
MIME 36/0 0/36 63.2/65.0 F-M 
FIM 
Significant 
difference in 
motor 
recovery 
Hesse 
2005 
Ischemic 
(first stroke) 
7.9/7.3 4-8 wk RT vs. 
electrical 
stimulation 
Bi-Manu-
Track 
20/0 0/20 65.4/64.0 F-M Superior 
improvement 
in upper limb 
control and 
power 
Daly 2005 Hemorrhagic, 
ischemic 
21/23 >12 mo RT vs. 
functional 
neuromuscular 
stimulation 
and motor 
earning 
InMotion 
Shoulder-
Elbow 
Robot 
90/0 0/90 21-62 F-M Significant 
gains in F-M 
upper-limb 
coordination 
Kahn 
2006 
? 3.5/3.2 75.8/103.1 
mo 
RT vs. task-
matched 
amount of 
unassisted 
reaching 
ARM 
Guide 
61/0 0/61 55.6/55.9 Ch McM Robotically 
assisting in 
reaching 
successfully 
improved 
arm 
movement 
ability 
Lum 2006 ? 8.4/5.0 10.0/10.6 
wk 
RT vs. 
conventional 
therapy 
MIME 45/0 0/45 69.8/59.9 F-M 
FIM 
Robot-
assisted 
treatment 
gains 
exceeded 
those 
expected 
from 
spontaneous 
recovery 
 
